Genomatix Software GmbH today announced that it has achieved GeneChip-compatibleTM
status for several products with the Affymetrix Inc.
GeneChip® microarray platform and that it has joined Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible software provider, Genomatix is committed to seamlessly integrating its entire microarray analysis pipeline with the Affymetrix technology.
The Genomatix line of products which achieved GeneChip-compatibleTM status consists of ChipInspector, ChipInspector TL, ElDorado, GEMS Launcher, and BiblioSphere PathwayEdition. With those products Genomatix provides a broad set of solutions for Affymetrix GeneChip users, including analysis of data from Affymetrix whole-genome tiling and exon arrays.
"We are proud of having met the high standards of Affymetrix and earning GeneChip-compatibleTM status. The tight integration of our microarray analysis pipeline with the Affymetrix platform will stimulate exciting new results in both basic and applied biomedical R&D," said Klaus May, Director of Sales and Marketing at Genomatix. "Especially in conjunction with the new Affymetrix tiling and exon array technology, I expect that our tools will drive far greater understanding of genomic organization and transcriptome regulation."
"Affymetrix is pleased to be working with Genomatix in their efforts to develop advanced tools for analyzing GeneChip data," said Steve Lincoln, vice president of Informatics at Affymetrix. "We are particularly excited to see the emergence of next-generation commercial software which can help bring unprecedented levels of genomic resolution into the hands of applied biomedical researchers."
Source:Genomatix Software GmbH
Page: 1 Related biology news :1
. Genomatix, AAAS ink agreement2
. Genomatix technology facilitates de novo identification of new renal disease associated genes3
. MatBase -- A new transcription factor knowledge base released by Genomatix4
. Application of Genomatix in silico methods reveals novel cancer associated genes5
. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering6
. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible7
. Breakthrough Microarray-based Technology for the Study of Cancer8
. Nanogen Issued Patent for Electronic Microarray With Memory9
. Characterizing Skin Cancer by Microarrays10
. Microarrays as phenotype11
. $6.5 Million Grant for Microarray Center at Yale School of Medicine